RKDA logo

Arcadia Biosciences (RKDA) EBITDA

Annual EBITDA

-$13.58 M
+$1.17 M+7.94%

December 31, 2023

Summary

Performance

1-Year Change

+7.94%

3-Year Change

-149.55%

5-Year Change

-1.97%

15-Year Change

+7.35%

RKDA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

17.97%
RKDA annual EBITDA is higher than 17.97% of companies in Consumer Defensive sector

High & Low

All-time High

-$5.44 M

3-Year Low

-$27.71 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RKDA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
RKDA next annual earnings announcement is scheduled for Feb 28, 2025

OtherRKDAprofitabilitymetrics:

Annual Revenue

$5.33 M
RKDA annual revenue is $5.33 million

Annual Net Income

-$13.98 M
RKDA annual net profit is -$13.98 million

Annual EBIT

-$13.87 M
RKDA annual earnings before interest & taxes is -$13.87 million

Annual EPS

-$11.30
RKDA annual earnings per share is -$11.30

Quarterly EBITDA

-$1.75 M
+$233.00 K+11.73%

September 30, 2024

Summary

Performance

3-Month Change

+11.73%

1-Year Change

-34.02%

3-Year Change

+54.05%

5-Year Change

+54.05%

RKDA Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

15.11%
RKDA quarterly EBITDA is higher than 15.11% of companies in Consumer Defensive sector

High & Low

All-time High

$8.75 M
RKDA quarterly EBITDA is currently -120.03% below its historical high of $8.75 million

3-Year Low

-$8.90 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RKDA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RKDA next earnings announcement is scheduled for Feb 28, 2025

OtherRKDAprofitabilitymetrics:

Quarterly Revenue

$1.54 M
RKDA quarterly revenue is $1.54 million

Quarterly Net Income

-$1.61 M
RKDA quarterly net profit is -$1.61 million

Quarterly EBIT

-$1.76 M
RKDA quarterly earnings before interest & taxes is -$1.76 million

Quarterly EPS

-$1.18
RKDA quarterly earnings per share is -$1.18

TTM EBITDA

-$15.61 M
-$445.00 K-2.93%

September 30, 2024

Summary

Performance

3-Month Change

-2.93%

1-Year Change

-45.77%

3-Year Change

+4.67%

5-Year Change

+4.67%

RKDA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

12%
RKDA TTM EBITDA is higher than 12% of companies in Consumer Defensive sector

High & Low

All-time High

-$2.17 M

3-Year Low

-$27.55 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RKDA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RKDA next earnings announcement is scheduled for Feb 28, 2025

OtherRKDAprofitabilitymetrics:

TTM Revenue

$5.75 M
RKDA TTM revenue is $5.75 million

TTM Net Income

-$5.83 M
RKDA TTM net profit is -$5.83 million

TTM EBIT

-$15.76 M
RKDA TTM earnings before interest & taxes is -$15.76 million

TTM EPS

-$4.17
RKDA TTM earnings per share is -$4.17

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$13.58 M
RKDA annual EBITDA is -$13.58 million

Annual Net Income

-$13.98 M
RKDA annual net profit is -$13.98 million

Annual Interest Expense

-
RKDA annual interest expense value is unknown

Annual Income Tax

$8000.00
RKDA annual income tax is $8000.00

Annual D&A

$287.00 K
RKDA annual depreciation & amortization is $287.00 thousand

RKDA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.9%-34.0%-45.8%
3 y3 years-149.6%+54.0%+4.7%
5 y5 years-2.0%+54.0%+4.7%

RKDA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+51.0%-34.0%+80.3%-45.8%+43.3%
5 y5-year-149.6%+52.6%-120.0%+82.1%-330.0%+45.5%
alltimeall time-149.6%+52.6%-120.0%+87.6%-621.0%+45.5%

Arcadia Biosciences EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.75 M(-11.7%)
-$15.61 M(+2.9%)
Jun 2024
-
-$1.99 M(-33.2%)
-$15.16 M(+4.1%)
Mar 2024
-
-$2.98 M(-66.6%)
-$14.57 M(-5.5%)
Dec 2023
-$13.58 M(-7.9%)
-$8.90 M(+580.1%)
-$15.41 M(+43.9%)
Sep 2023
-
-$1.31 M(-5.7%)
-$10.71 M(-19.5%)
Jun 2023
-
-$1.39 M(-63.6%)
-$13.30 M(-18.8%)
Mar 2023
-
-$3.81 M(-9.1%)
-$16.37 M(-5.8%)
Dec 2022
-$14.75 M(-46.8%)
-$4.20 M(+7.6%)
-$17.38 M(-18.5%)
Sep 2022
-
-$3.90 M(-12.5%)
-$21.32 M(-13.3%)
Jun 2022
-
-$4.46 M(-7.5%)
-$24.60 M(-10.7%)
Mar 2022
-
-$4.82 M(-40.8%)
-$27.55 M(+32.6%)
Dec 2021
-$27.71 M(+409.3%)
-$8.14 M(+13.4%)
-$20.78 M(+434.1%)
Sep 2021
-
-$7.18 M(-3.1%)
-$3.89 M(+7.2%)
Jun 2021
-
-$7.41 M(-480.6%)
-$3.63 M(-39.6%)
Mar 2021
-
$1.95 M(-77.8%)
-$6.01 M(+10.5%)
Dec 2020
-$5.44 M(-81.0%)
$8.75 M(-226.5%)
-$5.44 M(-73.4%)
Sep 2020
-
-$6.92 M(-29.3%)
-$20.45 M(-26.1%)
Jun 2020
-
-$9.79 M(-489.0%)
-$27.66 M(+103.5%)
Mar 2020
-
$2.52 M(-140.2%)
-$13.60 M(-52.6%)
Dec 2019
-$28.67 M
-$6.26 M(-55.7%)
-$28.67 M(+24.4%)
Sep 2019
-
-$14.13 M(-430.2%)
-$23.04 M(+420.0%)
Jun 2019
-
$4.28 M(-134.1%)
-$4.43 M(-66.5%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$12.56 M(+1890.3%)
-$13.24 M(+196.2%)
Dec 2018
-$13.32 M(-9.1%)
-$631.00 K(-114.1%)
-$4.47 M(-33.7%)
Sep 2018
-
$4.48 M(-198.9%)
-$6.74 M(-56.9%)
Jun 2018
-
-$4.53 M(+19.7%)
-$15.62 M(+6.6%)
Mar 2018
-
-$3.79 M(+30.5%)
-$14.66 M(+0.0%)
Dec 2017
-$14.65 M(-18.5%)
-$2.90 M(-34.1%)
-$14.65 M(-14.0%)
Sep 2017
-
-$4.40 M(+23.3%)
-$17.05 M(+3.9%)
Jun 2017
-
-$3.57 M(-5.8%)
-$16.41 M(-3.3%)
Mar 2017
-
-$3.79 M(-28.5%)
-$16.97 M(-5.6%)
Dec 2016
-$17.98 M(+20.0%)
-$5.30 M(+41.0%)
-$17.98 M(+12.4%)
Sep 2016
-
-$3.76 M(-9.1%)
-$16.00 M(-0.8%)
Jun 2016
-
-$4.13 M(-13.7%)
-$16.12 M(+9.4%)
Mar 2016
-
-$4.79 M(+44.3%)
-$14.73 M(-1.6%)
Dec 2015
-$14.98 M(-2.7%)
-$3.32 M(-14.5%)
-$14.98 M(+13.6%)
Sep 2015
-
-$3.88 M(+41.5%)
-$13.19 M(-17.4%)
Jun 2015
-
-$2.74 M(-45.5%)
-$15.97 M(-10.9%)
Mar 2015
-
-$5.04 M(+229.5%)
-$17.92 M(+16.4%)
Dec 2014
-$15.39 M(+51.3%)
-$1.53 M(-77.1%)
-$15.39 M(-4.0%)
Sep 2014
-
-$6.67 M(+42.2%)
-$16.03 M(+71.2%)
Jun 2014
-
-$4.69 M(+86.8%)
-$9.36 M(+100.3%)
Mar 2014
-
-$2.51 M(+15.9%)
-$4.67 M(+115.9%)
Dec 2013
-$10.17 M(+4.4%)
-$2.17 M
-$2.17 M
Dec 2012
-$9.74 M
-
-

FAQ

  • What is Arcadia Biosciences annual EBITDA?
  • What is the all time high annual EBITDA for Arcadia Biosciences?
  • What is Arcadia Biosciences annual EBITDA year-on-year change?
  • What is Arcadia Biosciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Arcadia Biosciences?
  • What is Arcadia Biosciences quarterly EBITDA year-on-year change?
  • What is Arcadia Biosciences TTM EBITDA?
  • What is the all time high TTM EBITDA for Arcadia Biosciences?
  • What is Arcadia Biosciences TTM EBITDA year-on-year change?

What is Arcadia Biosciences annual EBITDA?

The current annual EBITDA of RKDA is -$13.58 M

What is the all time high annual EBITDA for Arcadia Biosciences?

Arcadia Biosciences all-time high annual EBITDA is -$5.44 M

What is Arcadia Biosciences annual EBITDA year-on-year change?

Over the past year, RKDA annual EBITDA has changed by +$1.17 M (+7.94%)

What is Arcadia Biosciences quarterly EBITDA?

The current quarterly EBITDA of RKDA is -$1.75 M

What is the all time high quarterly EBITDA for Arcadia Biosciences?

Arcadia Biosciences all-time high quarterly EBITDA is $8.75 M

What is Arcadia Biosciences quarterly EBITDA year-on-year change?

Over the past year, RKDA quarterly EBITDA has changed by -$445.00 K (-34.02%)

What is Arcadia Biosciences TTM EBITDA?

The current TTM EBITDA of RKDA is -$15.61 M

What is the all time high TTM EBITDA for Arcadia Biosciences?

Arcadia Biosciences all-time high TTM EBITDA is -$2.17 M

What is Arcadia Biosciences TTM EBITDA year-on-year change?

Over the past year, RKDA TTM EBITDA has changed by -$4.90 M (-45.77%)